Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Metabolic Syndrome × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 3 Vasculitis 2 Uveitis 2 Granulomatosis with Polyangiitis 2 Arthritis, Juvenile 2 Temporomandibular Joint Disorders 1 Stomatitis 1 Pneumonia 1 Neoplasms 1 Metabolic Syndrome 1 Asthma 1 Arthritis, Rheumatoid 1

Interventions

Pioglitazone 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2/3 Completed

Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡